Warberg Asset Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-22,900
Closed -$6.64K 248
2023
Q1
$6.64K Hold
22,900
﹤0.01% 210
2022
Q4
$5.73K Sell
22,900
-1,300
-5% -$398 ﹤0.01% 223
2022
Q3
$11K Buy
24,200
+4,200
+21% +$2.48K ﹤0.01% 230
2022
Q2
$10K Buy
+20,000
New +$11.1K ﹤0.01% 208

Other funds holding DRTSW

Warberg Asset Management's DRTSW Position: Q2 2023 in Review

Warberg Asset Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2023, closing a stake of 22,900 shares — an estimated $6.64K sold.

Warberg Asset Management first reported a position in DRTSW in Q2 2022 and held it in 4 quarters. The position peaked at $11K in Q3 2022. 28 funds tracked by Wall St. Rank hold DRTSW as of Q2 2023.

  • Warberg Asset Management reported no remaining Alpha Tau Medical Warrant position as of Q2 2023 after selling out during the quarter.
  • Warberg Asset Management sold 22,900 Alpha Tau Medical Warrant shares in Q2 2023, an estimated $6.64K.
  • Warberg Asset Management first reported a position in Alpha Tau Medical Warrant in Q2 2022 and held it in 4 quarters.
  • Warberg Asset Management's Alpha Tau Medical Warrant position peaked at $11K in Q3 2022.
  • 28 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2023.

Based on Warberg Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.